Sleep Disorders Flashcards

1
Q

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Insomnia is the most common sleep condition and is characterized by difficulty falling asleep (sleep initiation or sleep latency), reduced sleep duration and/or poor sleep quality.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A diagnosis of chronic insomnia occurs when the patient has symptoms at least ________ for at least _____________, despite adequate opportunity to sleep.

A

3 times per week

3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

________________ for insomnia is preferred and includes changes to sleep hygiene that can reduce the need for drugs.

A

(CBT) cognitive behavioral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

It is important to treat any underlying medical condition that may be contributing and discontinue medications that can worsen insomnia.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Natural products used for sleep:

A

melatonin
valerian
Kava - Not recommended due to risk of hepatotoxicity.
chamomile tea - drinking in the evening can help to feel calmer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The American Academy of Sleep Medicine (AASM) guidelines state that the following treatments are NOT recommended for chronic use:

A

diphenhydramine
melatonin
tiagabine
trazodone
valerian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Key Drugs that can worsen insomnia:

A
  • acetylcholinesterase inhibitors
  • alcohol
  • antiretrovirals
  • aripiprazole
  • atomoxetine (stimulant)
  • bupropion (activating)
  • caffeine
  • decongestants
  • diuretics (due to nocturia)
    -fluoxetine (activating)
  • steroids
  • stimulants
  • varenicline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Insomnia
- difficulty with sleep
Sleep initiation/latency: falling asleep
Sleep duration: staying asleep
Sleep quality: awakening after sleep onset

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-drug treatments first:

CBT
Treat other conditions
Stop medications worsening insomnia
Try natural products

A
  • keep the bedroom dark, comfortable, and quiet
  • keep to a regular sleep schedule
  • avoid daytime naps, even after a poor night of sleep, or limit to 30 mins
  • reserve the bedroom for sleep and other appropriate activities (no TV)
  • turn the face of the clock aside to minimize anxiety about falling asleep
  • Do not eat heavy meals right before bedtime
  • do not take caffeine in the afternoon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Need Help Falling asleep (Initiation):

Z-drugs or ramelteon
eszopiclone
zolpidem
zaleplon

A

Need help staying asleep (Duration):

eszopiclone
zolpidem
suvorexant
doxepin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

EZ TIP for excellent Zzzzzzzzz (sleep): For help falling asleep (Initiation) and staying asleep (Duration):

E
Z

A

Eszopiclone
Zolpidem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Non-benzodiazepines preferred.
Can consider benzodiazepines for short term treatment.
OTC drugs sometimes used.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Beers Criteria, benzodiazepines, non-benzodiazepine hypnotics and first-generation antihistamines are considered potentially inappropriate in patients aged 65 years old and older. If benzodiazepines are used (LOT) drugs are preferred in elderly due to the lower risk of adverse reactions.

A

Lorazepam

Oxazepam

Temazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lunesta

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

eszopiclone C-IV

Class: Hypnotics

Indications: insomnia

MOA: increase GABA (inhibitory neurotransmitter) at the benzodiazepine receptor. This causes CNS depression.

Dosage forms:

Dosing:

Max dose:

Contraindications:
History of complex sleep behavior

Warnings:
Increase risk of CNS depression and next day impairment with < 7-8 hours of sleep (especially with higher doses or coadministration of CNS depressants or alcohol).

Potential for abuse and dependance (can cause withdrawal symptoms if used longer than 2 weeks)

Side Effects:
Somnolence, dizziness, ataxia, headache,
Parasomnias (unusual actions while you are sleeping, which the patient may be unaware of).

Monitoring:

Pearls/Notes:
C-IV
Preferred over benzodiazepines for first line treatment due to decrease abuse, dependence and tolerance.

Do not take with fatty food, a heavy meal or alcohol.

Drug-Drug/Food interactions:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ambien

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

zolpidem

Class: Hypnotics

Indications: insomnia

MOA: increase GABA (inhibitory neurotransmitter) at the benzodiazepine receptor. This causes CNS depression.

Dosage forms:

Dosing:

Max dose:

Contraindications:
History of complex sleep behavior

Warnings:
Increase risk of CNS depression and next day impairment with < 7-8 hours of sleep (especially with higher doses or coadministration of CNS depressants or alcohol).

Potential for abuse and dependance (can cause withdrawal symptoms if used longer than 2 weeks)

Side Effects:
Somnolence, dizziness, ataxia, headache,
Parasomnias (unusual actions while you are sleeping, which the patient may be unaware of).

Monitoring:

Pearls/Notes:
C-IV
Preferred over benzodiazepines for first line treatment due to decrease abuse, dependence and tolerance.

Do not take with fatty food, a heavy meal or alcohol.

Drug-Drug/Food interactions:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Edluar

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

zolpidem

Class: Hypnotics

Indications: insomnia

MOA: increase GABA (inhibitory neurotransmitter) at the benzodiazepine receptor. This causes CNS depression.

Dosage forms: Sublingual tablet

Dosing:

Max dose:

Contraindications:
History of complex sleep behavior

Warnings:
Increase risk of CNS depression and next day impairment with < 7-8 hours of sleep (especially with higher doses or coadministration of CNS depressants or alcohol).

Potential for abuse and dependance (can cause withdrawal symptoms if used longer than 2 weeks)

Side Effects:
Somnolence, dizziness, ataxia, headache,
Parasomnias (unusual actions while you are sleeping, which the patient may be unaware of).

Monitoring:

Pearls/Notes:
C-IV
Preferred over benzodiazepines for first line treatment due to decrease abuse, dependence and tolerance.

Do not take with fatty food, a heavy meal or alcohol.

Drug-Drug/Food interactions:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Zolpimist

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

zolpidem

Class: Hypnotics

Indications: insomnia

MOA: increase GABA (inhibitory neurotransmitter) at the benzodiazepine receptor. This causes CNS depression.

Dosage forms: oral spray

Dosing:

Max dose:

Contraindications:
History of complex sleep behavior

Warnings:
Increase risk of CNS depression and next day impairment with < 7-8 hours of sleep (especially with higher doses or coadministration of CNS depressants or alcohol).

Potential for abuse and dependance (can cause withdrawal symptoms if used longer than 2 weeks)

Side Effects:
Somnolence, dizziness, ataxia, headache,
Parasomnias (unusual actions while you are sleeping, which the patient may be unaware of).

Monitoring:

Pearls/Notes:
C-IV
Preferred over benzodiazepines for first line treatment due to decrease abuse, dependence and tolerance.

Do not take with fatty food, a heavy meal or alcohol.

Drug-Drug/Food interactions:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Sonata

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

zaleplon

Class: Hypnotics

Indications: insomnia

MOA: increase GABA (inhibitory neurotransmitter) at the benzodiazepine receptor. This causes CNS depression.

Dosage forms:

Dosing:

Max dose:

Contraindications:
History of complex sleep behavior

Warnings:
Increase risk of CNS depression and next day impairment with < 7-8 hours of sleep (especially with higher doses or coadministration of CNS depressants or alcohol).

Potential for abuse and dependance (can cause withdrawal symptoms if used longer than 2 weeks)

Side Effects:
Somnolence, dizziness, ataxia, headache,
Parasomnias (unusual actions while you are sleeping, which the patient may be unaware of).

Monitoring:

Pearls/Notes:
C-IV
Preferred over benzodiazepines for first line treatment due to decrease abuse, dependence and tolerance.

Do not take with fatty food, a heavy meal or alcohol.

Drug-Drug/Food interactions:

Use caution in combination with potent CYP3A4 inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

DayVigo

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

lemborexant

Class: orexin receptor antagonist

Indications:

MOA: The orexin neuropeptide signaling system promotes wakefulness. Orexin receptor antagonists block the orexin neuropeptide signaling system, resulting in drowsiness.

Dosage forms:

Dosing:

Max dose:

Contraindications:
Narcolepsy

Warnings:
Worsening depression/suicidal ideation, sleep paralysis, hallucinations, cataplexy-like symptoms (sudden loss of muscle tone), increased risk for complex sleep behavior, daytime impairment (risk increased with other CNS depressants).

Side Effects:
somnolence, headache, dizziness, abnormal dreams

Monitoring:

Pearls/Notes:
Should be taken on an empty stomach (food delays absorption)
Not recommended in patients with severe hepatic impairment.

Drug-Drug/Food interactions:

22
Q

Belsomra

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

suvorexant

Class:

Indications:

MOA:

Dosage forms:

Dosing:

Max dose:

Contraindications:

Warnings:

Side Effects:

Monitoring:

Pearls/Notes:

Drug-Drug/Food interactions:

23
Q
A
24
Q

Rozerem

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

ramelteon

Class: melatonin receptor agonists

Indications:

MOA: drug acts at the melatonin receptors, MT1 and MT2. This promotes sleepiness and regulates the circadian rhythm to coordinate the sleep-wake cycle.

Dosage forms:

Dosing:

Max dose:

Contraindications:
contraindicated with fluvoxamine (increases serum concentrations of ramelteon)

Warnings:

Side Effects:
somnolence, dizziness

Monitoring:

Pearls/Notes:

Not limited to short use
Not controlled
Good for helping fall asleep.

Drug-Drug/Food interactions:

25
Q

Hetliaz

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

tasimelteon

Class: melatonin receptor agonists

Indications:

MOA: drug acts at the melatonin receptors, MT1 and MT2. This promotes sleepiness and regulates the circadian rhythm to coordinate the sleep-wake cycle.

Dosage forms:

Dosing:

Max dose:

Contraindications:

Warnings:

Side Effects:

Monitoring:

Pearls/Notes:
Not limited to short use
Not controlled
tasimelteon - for non-24-hour sleep wake disorder

Drug-Drug/Food interactions:

26
Q
A
27
Q

Silenor

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

doxepin

Class: tricyclic antidepressant

Indications: insomnia

MOA: inhibits NE and 5-HT reuptake. They also block acetylcholine and histamine receptors which contribute to side effects (somnolence).

Dosage forms:

Dosing: 3-6mg PO QDHS

3mg if > or = to 65 years old.

Max dose:

Boxed Warnings:
increase in suicidal thoughts or actions in some children, teenagers or young adults within the first few months of treatment or when the dose is changed.

Contraindications:
Requires a w-week washout period for MAO inhibitors.

Warnings:

Side Effects:
somnolence, possibility of anticholinergic side effects.

Monitoring:

Pearls/Notes:
Doxepin ER (Silenor) the brand name is FDA-approved for sleep.
Good for staying asleep

Drug-Drug/Food interactions:

28
Q
A
29
Q

Restoril

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

temazepam

Class: benzodiazepine

Indications:

MOA: drug enhances GABA, an inhibitory neurotransmitter, causing CNS depression.

Dosage forms:

Dosing:

Max dose:

Contraindications:
pregnancy due to observed teratogenicity*

Warnings:
complex sleep behaviors (e.g. sleep-driving) have been noted.
-drowsiness, dizziness, ataxia, lightheadedness
-anterograde amnesia (some of the events that occur after taking BZD cannot be stored as memories - forgetting what happens)

Side Effects:
Drowsiness, dizziness/ increased fall risk, cognitive impairment

Monitoring:

Pearls/Notes:
C-IV drugs; there is a risk of physical (physiological) dependence, abuse (addiction) and tolerance.
- Increased risk of falls, use with caution in those at high risk
- cross the placenta
- For Short Term use only, 1-2 weeks.
- Slow taper required if used long term.

Drug-Drug/Food interactions:

30
Q

estazolam

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

Class: benzodiazepine

Indications:

MOA: drug enhances GABA, an inhibitory neurotransmitter, causing CNS depression.

Dosage forms:

Dosing:

Max dose:

Contraindications:
pregnancy due to observed teratogenicity*

Warnings:
complex sleep behaviors (e.g. sleep-driving) have been noted.
-drowsiness, dizziness, ataxia, lightheadedness
-anterograde amnesia (some of the events that occur after taking BZD cannot be stored as memories - forgetting what happens)

Side Effects:
Drowsiness, dizziness/ increased fall risk, cognitive impairment

Monitoring:

Pearls/Notes:
C-IV drugs; there is a risk of physical (physiological) dependence, abuse (addiction) and tolerance.
- Increased risk of falls, use with caution in those at high risk
- cross the placenta
- For Short Term use only, 1-2 weeks.
- Slow taper required if used long term.

  • *Estazolam do not use with potent CYP3A4 inhibitors (e.g ketoconazole, itraconazole)

Drug-Drug/Food interactions:

31
Q

Doral

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

quazepam

Class: benzodiazepine

Indications:

MOA: drug enhances GABA, an inhibitory neurotransmitter, causing CNS depression.

Dosage forms:

Dosing:

Max dose:

Contraindications:
pregnancy due to observed teratogenicity*

Warnings:
complex sleep behaviors (e.g. sleep-driving) have been noted.
-drowsiness, dizziness, ataxia, lightheadedness
-anterograde amnesia (some of the events that occur after taking BZD cannot be stored as memories - forgetting what happens)

Side Effects:
Drowsiness, dizziness/ increased fall risk, cognitive impairment

Monitoring:

Pearls/Notes:
C-IV drugs; there is a risk of physical (physiological) dependence, abuse (addiction) and tolerance.
- Increased risk of falls, use with caution in those at high risk
- cross the placenta
- For Short Term use only, 1-2 weeks.
- Slow taper required if used long term.

Drug-Drug/Food interactions:

32
Q

flurazepam

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

Class: benzodiazepine

Indications:

MOA: drug enhances GABA, an inhibitory neurotransmitter, causing CNS depression.

Dosage forms:

Dosing:

Max dose:

Contraindications:
pregnancy due to observed teratogenicity*

Warnings:
complex sleep behaviors (e.g. sleep-driving) have been noted.
-drowsiness, dizziness, ataxia, lightheadedness
-anterograde amnesia (some of the events that occur after taking BZD cannot be stored as memories - forgetting what happens)

Side Effects:
Drowsiness, dizziness/ increased fall risk, cognitive impairment

Monitoring:

Pearls/Notes:
C-IV drugs; there is a risk of physical (physiological) dependence, abuse (addiction) and tolerance.
- Increased risk of falls, use with caution in those at high risk
- cross the placenta
- For Short Term use only, 1-2 weeks.
- Slow taper required if used long term.

Drug-Drug/Food interactions:

33
Q

Halcion

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

triazolam

Class: benzodiazepine

Indications:

MOA: drug enhances GABA, an inhibitory neurotransmitter, causing CNS depression.

Dosage forms:

Dosing:

Max dose:

Contraindications:
pregnancy due to observed teratogenicity*

Warnings:
complex sleep behaviors (e.g. sleep-driving) have been noted.
-drowsiness, dizziness, ataxia, lightheadedness
-anterograde amnesia (some of the events that occur after taking BZD cannot be stored as memories - forgetting what happens)

Side Effects:
Drowsiness, dizziness/ increased fall risk, cognitive impairment

Monitoring:

Pearls/Notes:
C-IV drugs; there is a risk of physical (physiological) dependence, abuse (addiction) and tolerance.
- Increased risk of falls, use with caution in those at high risk
- cross the placenta
-** triazolam: associated with higher rebound insomnia and daytime anxiety; contraindicated with azole antifungals, protease inhibitors and other CYP3A4 inhibitors
- For Short Term use only, 1-2 weeks.
- Slow taper required if used long term.

Drug-Drug/Food interactions:

34
Q

L-O-T:

A

Lorazepam
Oxazepam
Temazepam
- these benzo’s are thought to be safer in liver disease
- considered safer for patient’s 65 years and older since these medications do not have active metabolites.

35
Q

Bendryl

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

diphenhydramine

Class: antihistamine

Indications:

MOA: drug competes with and blocks histamine H1 receptors

Dosage forms:

Dosing: 50mg PO QDHS

Max dose:

Contraindications:

Warnings:

Side Effects: sedation (tolerance to sedative effects can develop after 10 days of use), confusion (can exacerbate memory/cognition difficulty)

Antihistamines may cause paradoxical excitation in young children; DO NOT USE doxylamine in children < 12 years old.

Peripheral anticholinergic side effects: dry mouth, urinary retention (makes it very difficult for males with BPH to urinate), dry/blurry vision, constipation

Best to avoid in BPH (can worsen symptoms) and glaucoma (can elevate IOP)

Monitoring:

Pearls/Notes:
BEERS Criteria - (Anticholinergic Effects)

Drug-Drug/Food interactions:

36
Q

Unisom

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

doxylamine

Class: antihistamine

Indications:

MOA: drug competes with and blocks histamine H1 receptors

Dosage forms:

Dosing: 25mg PO QDHS

Max dose:

Contraindications:

Warnings:

Side Effects: sedation (tolerance to sedative effects can develop after 10 days of use), confusion (can exacerbate memory/cognition difficulty)

Antihistamines may cause paradoxical excitation in young children; DO NOT USE doxylamine in children < 12 years old.

Peripheral anticholinergic side effects: dry mouth, urinary retention (makes it very difficult for males with BPH to urinate), dry/blurry vision, constipation

Best to avoid in BPH (can worsen symptoms) and glaucoma (can elevate IOP)

Monitoring:

Pearls/Notes:
BEERS Criteria - (Anticholinergic Effects)

Drug-Drug/Food interactions:

37
Q

(RLS) Restless Leg Syndrome:

A

Urge to move lower legs.
- worse at night
- relieved with movement

38
Q

Drug treatment for RLS: increase (DA) dopamine

“usually used in PD for movement disorder”

A

dopamine agonists
- (Mirapex) pramipexole
- (Requip) ropinirole
- (Neupro) rotigotine - patch
- (Horizant) gabapentin enacarbil - approved for RLS and postherpetic neuralgia. (Take with food, swallow whole)

39
Q

For RLS, the immediate release (IR) formulation is taken 1-3 hours before bedtime.**

A

(Neupro) rotigotine is a dopamine agonist that comes in a patch formulation (used for both PD and RLS). The patch is applied once daily, and patients must be counseled on appropriate use. (e.g. do not apply a heat source over the patch, remove the patch before an MRI procedure, rotate sites to avoid skin irritation.

40
Q

Dopamine agonists cause:

A

orthostasis, somnolence and nausea that is dose related.

41
Q
A
42
Q

Narcolepsy:

A

is excessive daytime sleepiness with cataplexy (sudden loss of muscle tone) and sleep paralysis.
- sudden and uncontrollable sleep attacks with cataplexy (sudden loss of muscle tone)
- poor control of normal sleep-wake cycle
- excessive sleepiness

43
Q

Drug Treatment for Narcolepsy:

Stimulants
- modafinil (Provigil)
- armodafinil (Nuvigil)

Sodium oxybate (Xyrem)

calcium, magnesium, potassium and sodium oxybate (Xywav)

Several of the ADHD stimulants also have an indication for Narcolepsy:
- dextroamphetamine
- dextroamphetamine/amphetamine
- methylphenidate

A
44
Q
A
45
Q

Provigil

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

modafinil

Class: stimulant for wakefulness

Indications: narcolepsy, obstructive sleep apnea (to help with daytime sleepiness) and shift work disorder.

MOA:

Dosage forms:

Dosing:

Max dose:

Contraindications:

Warnings:
Avoid with pre-existing cardiac conditions, caution with hepatic or renal dysfunction, psychiatric disorders and Tourette’s syndrome.

Side Effects:
*Severe rash, can be life threatening (SJS), headache, insomnia, anxiety, nausea

Monitoring:

Pearls/Notes:
C-IV

Drug-Drug/Food interactions:

46
Q

Nuvigil

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

armodafinil

Class: stimulant for wakefulness

Indications: narcolepsy, obstructive sleep apnea (to help with daytime sleepiness) and shift work disorder.

MOA:

Dosage forms:

Dosing:

Max dose:

Contraindications:

Warnings:
Avoid with pre-existing cardiac conditions, caution with hepatic or renal dysfunction, psychiatric disorders and Tourette’s syndrome.

Side Effects:
*Severe rash, can be life threatening (SJS), headache, insomnia, anxiety, nausea

Monitoring:

Pearls/Notes:
C-IV

Drug-Drug/Food interactions:

47
Q

Xyrem

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

sodium oxybate

Class:

Indications: narcolepsy with cataplexy (sudden loss of muscle tone)

MOA:

Dosage forms:

Dosing:

Max dose:

Boxed warning:
Strong CNS depressant: respiratory depression, coma and death can result; risk is increased when taken with other CNS depressants.

Contraindications:
Use with sedative hypnotics or alcohol

Warnings:
depression, suicide, psychosis, anxiety, sleepwalking

Side Effects:
dizziness, confusion, nausea

Monitoring:

Pearls/Notes:
-derived from GABA
C-III
- **Restricted access through Xyrem REMS program - “date rape” drug
- drug helps with sleep at night and are generally used with daytime stimulants.
- High sodium content; limiting dietary sodium intake may be required

Drug-Drug/Food interactions:

48
Q

Xywav

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

calcium, magnesium, potassium and sodium oxybates (Xywav)

Class:

Indications: narcolepsy with cataplexy (sudden loss of muscle tone)

MOA:

Dosage forms:

Dosing:

Max dose:

Boxed warning:
Strong CNS depressant: respiratory depression, coma and death can result; risk is increased when taken with other CNS depressants.

Contraindications:
Use with sedative hypnotics or alcohol

Warnings:
depression, suicide, psychosis, anxiety, sleepwalking

Side Effects:
dizziness, confusion, nausea

Monitoring:

Pearls/Notes:
-derived from GABA
C-III
- **Restricted access through Xyrem REMS program - “date rape” drug
- drug helps with sleep at night and are generally used with daytime stimulants.
- High sodium content; limiting dietary sodium intake may be required

Drug-Drug/Food interactions:

49
Q
A
50
Q

Wakix

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

pitolisant

51
Q

Sunosi

Class:
Indications:
MOA:
Dosage forms:
Dosing:
Max dose:
Contraindications:
Warnings:
Side Effects:
Monitoring:
Pearls/Notes:
Drug-Drug/Food interactions:

A

solriamfetol

52
Q
A